By staff writers

April 10, 2019 -- Imaging software developer Mirada Medical has received a new investment of 6 million pounds (7 million euros).

The investment was led by private equity healthcare firm Apposite Capital and included Mirada's founding investor, AlbionVC, and other private investors, according to Mirada.

The company said it would use the proceeds to accelerate product development milestones and improve the market accessibility of its artificial intelligence-based software applications. The software is intended to boost cancer treatment planning applications and improve personalized care.

Copyright © 2019

To read this and get access to all of the exclusive content on create a free account or sign-in now.

Member Sign In:
MemberID or Email Address:  
Do you have a password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking